3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with Experimental Lung Inflammation in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hoedemaekers, CW; Kox, M; Peters, E; Pickkers, P; Pompe, JC; Scheffer, GJ; van der Hoeven, JG; van der Laak, JW; Vaneker, M | 1 |
1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and Experimental Lung Inflammation
Article | Year |
---|---|
α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-α production and lung injury.
Topics: Acute Lung Injury; alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Cholinesterase Inhibitors; Interleukin-10; Lipopolysaccharides; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Neostigmine; Neutrophil Infiltration; Nicotinic Agonists; Nicotinic Antagonists; Pneumonia; Pulmonary Alveoli; Pyridines; Receptors, Nicotinic; Respiration, Artificial; Tumor Necrosis Factor-alpha; Ventilator-Induced Lung Injury | 2011 |